Neuroprotective effects of curcumin on endothelin-1 mediated cell death in hippocampal neurons

Nutritional Neuroscience

Volumn 20, Issue 5, 2017, Pages 273-283

  Stankowska, Dorota L ^a   Krishnamoorthy, Vignesh R ^b   Ellis, Dorette Z ^c   Krishnamoorthy, Raghu R ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c Department of Pharmacotherapy   (United States)

Author keywords

Alzheimer's disease; Curcumin; Endothelin; Neuroprotection; Primary hippocampal neurons

Indexed keywords

CASPASE 3; CASPASE 7; CURCUMIN; ENDOTHELIN 1; FODRIN; MICROTUBULE ASSOCIATED PROTEIN 2; ACTIN BINDING PROTEIN; CARRIER PROTEIN; NEUROPROTECTIVE AGENT; PROTEIN C JUN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL LOSS; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; HIPPOCAMPAL NEURON; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MTT ASSAY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CASPASE 3; CASPASE 7; CELL DEATH; CELLS, CULTURED; CURCUMIN; ENDOTHELIN-1; HIPPOCAMPUS; MICROFILAMENT PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84978476460     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1080/1028415X.2015.1119377     Document Type: Article

References (67)

1. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV., Curcumin:from ancient medicine to current clinical trials. Cell Mol Life Sci 2008;65(11):1631–52. doi:10.1007/s00018-008-7452-4
2. Lee W-H, Loo C-Y, Bebawy M, Luk F, Mason RS, Rohanizadeh R., Curcumin and its derivatives:their application in neuropharmacology and neuroscience in the 21st century. Curr Neuropharmacol 2013;11(4):338–78. doi:10.2174/1570159X11311040002
3. Gupta SC, Patchva S, Aggarwal BB., Therapeutic roles of curcumin:lessons learned from clinical trials. AAPS J 2012;15(1):195–218. doi:10.1208/s12248-012-9432-8
4. Gupta SC, Kismali G, Aggarwal BB., Curcumin, a component of turmeric:from farm to pharmacy. BioFactors 2013;39(1):2–13. doi:10.1002/biof.1079
5. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL., A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2005;2(2):131–6. doi:10.2174/1567205053585882
6. Ubhi K, Masliah E., Alzheimer's disease:recent advances and future perspectives. J Alzheimer's Dis 2013;33(0):S185–94.
7. Wang DB, Dayton RD, Zweig RM, Klein RL., Transcriptome analysis of a tau overexpression model in rats implicates an early pro-inflammatory response. Exp Neurol 2010;224(1):197–206. doi:10.1016/j.expneurol.2010.03.011
8. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332(6163):411–5. doi:10.1038/332411a0
9. Rubanyi GM, Polokoff MA., Endothelins:molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46(3):325–415.
10. Barton M, Yanagisawa M., Endothelin:20 years from discovery to therapy. This article is one of a selection of papers published in the special issue (part 2 of 2) on forefronts in endothelin. Can J Physiol Pharmacol 2008;86(8):485–98. doi:10.1139/Y08-059
11. Palmer J, Love S., Endothelin receptor antagonists:potential in Alzheimer's disease. Pharmacol Res 2011;63(6):525–31. doi:10.1016/j.phrs.2010.12.008
12. Seibenhener ML, Wooten MW., Isolation and culture of hippocampal neurons from prenatal mice. J Vis Exp [Internet]. 2012[cited 2014 Oct 14];(65). doi:10.3791/3634. PubMed PMID:22871921; PubMed Central PMCID:PMC3476399. Available from:http://www.jove.com/video/3634/isolation-and-culture-of-hippocampal-neurons-from-prenatal-mice
13. Xu W, Cormier R, Fu T, Covey DF, Isenberg KE, Zorumski CF, et al. Slow death of postnatal hippocampal neurons by GABAA receptor overactivation. J Neurosci 2000;20(9):3147–56.
14. Transcription Factor Brn-3b Overexpression Enhances Neurite Outgrowth in PC12 Cells Under Condition of Hypoxia-Springer. 2015;35(6):769–83. [cited 2015 May 26]; Available from:http://link.springer.com/article/10.1007/s10571-015-0171-0/fulltext.html.
15. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T., Role of the ET B receptor in retinal ganglion cell death in glaucomaThis article is one of a selection of papers published in the special issue (part 1 of 2) on Forefronts in Endothelin. Can J Physiol Pharmacol 2008;86(6):380–93. doi:10.1139/Y08-040
16. Karelina K, Alzate-Correa D, Obrietan K., Ribosomal S6 kinase regulates ischemia-induced progenitor cell proliferation in the adult mouse hippocampus. Exp Neurol 2014;253:72–81. doi:10.1016/j.expneurol.2013.11.022
17. Duerrschmidt N, Wippich N, Goettsch W, Broemme H-J, Morawietz H., Endothelin-1 induces NAD(P)H oxidase in human endothelial cells. Biochem Biophys Res Commun 2000;269(3):713–7. doi:10.1006/bbrc.2000.2354
18. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, et al. Endothelin-1 increases vascular superoxide via endothelinA-NADPH oxidase pathway in low-renin hypertension. Circulation 2003;107(7):1053–8. doi:10.1161/01.CIR.0000051459.74466.46
19. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, Black SM., Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 2001;89(4):357–64. doi:10.1161/hh1601.094983
20. Berridge MV, Tan AS., Trans-plasma membrane electron transport:a cellular assay for NADH- and NADPH-oxidase based on extracellular, superoxide-mediated reduction of the sulfonated tetrazolium salt WST-1. Protoplasma 1998;205(1–4):74–82. doi:10.1007/BF01279296
21. Selkoe DJ., Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J Alzheimers Dis 2001;3(1):75–80. doi:10.3233/JAD-2001-3111
22. Palmer JC, Baig S, Kehoe PG, Love S., Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by A? Am J Pathol 2009;175(1):262–70. doi:10.2353/ajpath.2009.081054
23. Palmer JC, Barker R, Kehoe PG, Love S., Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. J Alzheimer's Dis 2012;29(4):853–61.
24. Palmer JC, Tayler HM, Love S., Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. J Alzheimer's Dis 2013;36(3):577–87.
25. Minami M, Kimura M, Iwamoto N, Arai H., Endothelin-1-like immunoreactivity in cerebral cortex of Alzheimer-type dementia. Prog Neuro-Psychopharmacol Biol Psychiatry 1995;19(3):509–13. doi:10.1016/0278-5846(95)00031-P
26. Elesber AA, Bonetti PO, Woodrum JE, Zhu X-Y, Lerman LO, Younkin SG, et al. Bosentan preserves endothelial function in mice overexpressing APP. Neurobiol Aging 2006;27(3):446–50. doi:10.1016/j.neurobiolaging.2005.02.012
27. Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ., Curcumin and neurodegenerative diseases:a perspective. Expert Opin Investig Drugs 2012;21(8):1123–40. doi:10.1517/13543784.2012.693479
28. Mythri RB, Srinivas Bharath MM., Curcumin:a potential neuroprotective agent in Parkinson's disease. Curr Pharm Des 2012;18(1):91–9. doi:10.2174/138161212798918995
29. Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, et al. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease. Mol Neurodeg 2012;7(1):12. doi:10.1186/1750-1326-7-12
30. Xie L, Li X-K, Takahara S., Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol 2011;11(3):323–30. doi:10.1016/j.intimp.2010.08.013
31. Ahmed T, Enam SA, Gilani AH., Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Neuroscience 2010;169(3):1296–306. doi:10.1016/j.neuroscience.2010.05.078
32. Liao K-K, Wu M-J, Chen P-Y, Huang S-W, Chiu S-J, Ho C-T, et al. Curcuminoids promote neurite outgrowth in PC12 cells through MAPK/ERK- and PKC-dependent pathways. J Agric Food Chem 2012;60(1):433–43. doi:10.1021/jf203290r
33. Calabrese V, Guagliano E, Sapienza M, Mancuso C, Butterfield DA, Stella AMG., Redox regulation of cellular stress response in neurodegenerative disorders. Ital J Biochem 2006;55(3–4):263–82.
34. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 2007;1162:9–18. doi:10.1016/j.brainres.2007.05.071
35. Dong S, Zeng Q, Mitchell ES, Xiu J, Duan Y, Li C, et al. Curcumin enhances neurogenesis and cognition in aged rats:implications for transcriptional interactions related to growth and synaptic plasticity. PLoS One 2012;7(2):e31211. doi:10.1371/journal.pone.0031211
36. Wu A, Ying Z, Gomez-Pinilla F., Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol 2006;197(2):309–17. doi:10.1016/j.expneurol.2005.09.004
37. Borre YE, Panagaki T, Koelink PJ, Morgan ME, Hendriksen H, Garssen J, et al. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration and depression. Neuropharmacology 2014;79:738–49. doi:10.1016/j.neuropharm.2013.11.009
38. Chandra V, Pandav R, Dodge HH, Johnston JM, Belle SH, DeKosky ST, et al. Incidence of Alzheimer's disease in a rural community in India:the Indo-US study. Neurology 2001;57(6):985–9. doi:10.1212/WNL.57.6.985
39. Vas CJ, Pinto C, Panikker D, Noronha S, Deshpande N, Kulkarni L, et al. Prevalence of dementia in an urban Indian population. Int Psychogeriatr 2001;13(4):439–50. doi:10.1017/S1041610201007852
40. Ng T-P, Chiam P-C, Lee T, Chua H-C, Lim L, Kua E-H., Curry consumption and cognitive function in the elderly. Am J Epidemiol 2006;164(9):898–906. doi:10.1093/aje/kwj267
41. Baum L, Lam CWK, Cheung SK-K, Kwok T, Lui V, Tsoh J, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 2008;28(1):110–3. doi:10.1097/jcp.0b013e318160862c
42. Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, et al. Oral curcumin for Alzheimer's disease:tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 2012;4(5):43. doi:10.1186/alzrt146
43. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB., Bioavailability of curcumin:problems and promises. Mol Pharm 2007;4(6):807–18. doi:10.1021/mp700113r
44. Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006;6:10. doi:10.1186/1472-6882-6-10
45. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280(7):5892–901. doi:10.1074/jbc.M404751200
46. Purkayastha S, Berliner A, Fernando SS, Ranasinghe B, Ray I, Tariq H, et al. Curcumin blocks brain tumor formation. Brain Res 2009;1266:130–8. doi:10.1016/j.brainres.2009.01.066
47. Mishra S, Palanivelu K., The effect of curcumin (turmeric) on Alzheimer's disease:an overview. Ann Indian Acad Neurol 2008;11(1):13–9. doi:10.4103/0972-2327.40220
48. Zbarsky V, Datla KP, Parkar S, Rai DK, Aruoma OI, Dexter DT., Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic Res 2005;39(10):1119–25. doi:10.1080/10715760500233113
49. Shukla PK, Khanna VK, Ali MM, Khan MY, Srimal RC., Anti-ischemic effect of curcumin in rat brain. Neurochem Res 2008;33(6):1036–43. doi:10.1007/s11064-007-9547-y
50. Kuo Y-C, Lin C-C., Rescuing apoptotic neurons in Alzheimer's disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin. Int J Nanomed 2015;10:2653–72. doi:10.2147/IJN.S79528
51. Yoncheva K, Kondeva-Burdina M, Tzankova V, Petrov P, Laouani M, Halacheva SS., Curcumin delivery from poly(acrylic acid-co-methyl methacrylate) hollow microparticles prevents dopamine-induced toxicity in rat brain synaptosomes. Int J Pharm 2015;486(1–2):259–67. doi:10.1016/j.ijpharm.2015.03.061
52. Madane RG, Mahajan HS., Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration:design, characterization, and in vivo study. Drug Deliv 2014;1–9. doi:10.3109/10717544.2014.975382
53. McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, Xhillari D, et al. Inhalable curcumin:offering the potential for translation to imaging and treatment of Alzheimer's disease. J Alzheimers Dis 2014;2015;44(1):283–95.
54. Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway. ACS Nano 2014;8(1):76–103. doi:10.1021/nn405077y
55. Yang C, Zhang X, Fan H, Liu Y., Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Brain Res 2009;1282:133–41. doi:10.1016/j.brainres.2009.05.009
56. Dang H-Z, Li R-S, Wang H, Ren Y, Sun H-Y, Yang J-D, et al. Effect of curcumin on expression of AKT and p-AKT in hippocampus CA1 area of App/PS1 double transgenic mice. Zhongguo Zhong Yao Za Zhi 2013;38(19):3327–31.
57. Yanagisawa D, Taguchi H, Yamamoto A, Shirai N, Hirao K, Tooyama I., Curcuminoid binds to amyloid-β1–42 oligomer and fibril. J Alzheimers Dis 2011;24(Suppl. 2):33–42.
58. Herdegen T, Skene P, Bähr M., The c-Jun transcription factor–bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci 1997;20(5):227–31. doi:10.1016/S0166-2236(96)01000-4
59. Anderson AJ, Cummings BJ, Cotman CW., Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease:association with pathology. Exp Neurol 1994;125(2):286–95. doi:10.1006/exnr.1994.1031
60. Nijhawan D, Honarpour N, Wang X., Apoptosis in neural development and disease. Ann Rev Neurosci 2000;23(1):73–87. doi:10.1146/annurev.neuro.23.1.73
61. Trejo J, Massamiri T, Deng T, Dewji NN, Bayney RM, Brown JH., A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene. J Biol Chem 1994;269(34):21682–90.
62. Ham J, Babij C, Whitfield J, Pfarr CM, Lallemand D, Yaniv M, et al. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995;14(5):927–39. doi:10.1016/0896-6273(95)90331-3
63. Schlingensiepen K-H, Schlingensiepen R, Kunst M, Klinger I, Gerdes W, Seifert W, et al. Opposite functions of Jun-B and c-jun in growth regulation and neuronal differentiation. Dev Genet 1993;14(4):305–12. doi:10.1002/dvg.1020140408
64. He S, Minton AZ, Ma H-Y, Stankowska DL, Sun X, Krishnamoorthy RR., Involvement of AP-1 and C/EBPβ in upregulation of endothelin B (ETB) receptor expression in a rodent model of glaucoma. PLoS One 2013;8(11):e79183. doi:10.1371/journal.pone.0079183
65. He S, Park YH, Yorio T, Krishnamoorthy RR., Endothelin-mediated changes in gene expression in isolated purified rat retinal ganglion cells. Invest Opthalmol Visual Sci 2015;56(10):6144. doi:10.1167/iovs.15-16569
66. Rahman M, Zhang Z, Mody AA, Su D-M, Das HK., Intraperitoneal injection of JNK-specific inhibitor SP600125 inhibits the expression of presenilin-1 and Notch signaling in mouse brain without induction of apoptosis. Brain Res 2012;1448:117–28. doi:10.1016/j.brainres.2012.01.066
67. Balasubramanian S, Eckert RL., Curcumin suppresses AP1 transcription factor-dependent differentiation and activates apoptosis in human epidermal keratinocytes. J Biol Chem 2007;282(9):6707–15. doi:10.1074/jbc.M606003200